Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bone marrow transplant
Biotech
FDA delays Omeros' 2nd attempt at transplant drug’s approval
After receiving more information from the biotech, the FDA informed the company that the decision date has been pushed back to Dec. 26.
James Waldron
Aug 15, 2025 5:55am
Omeros stock up after data analysis spurs BLA resubmission plan
Dec 19, 2024 10:54am
A seventh known patient seems cured of HIV
Jul 18, 2024 1:59pm
Garuda bags $72M to advance off-the-shelf stem cell transplants
Sep 23, 2021 8:00am
OncoImmune nabs $56M round for late-stage COVID tests, leukemia
Sep 9, 2020 9:05am
Orca Bio breaches the surface with $192M
Jun 17, 2020 7:00am
